Navigation Links
Envera Files Patent for Low Temperature Growing Bacteria
Date:11/21/2013

West Chester, PA (PRWEB) November 21, 2013

Envera announced today the filing of a patent covering a proprietary group of low temperature growing bacteria. The psychrophilic microorganisms are naturally occurring bacteria, isolated from a stream in Pennsylvania, with the ability to grow at 4°C, and perhaps lower. These strains are expected to be commercially available the first week of December.

Mike Matheny, President and Owner of Envera stated, “There are applications, such as waste water treatment, pond maintenance, and soil or seed applications, where our products must work in low temperature environments.” “The addition of this group of bacteria to our microbial portfolio will greatly increase the breadth of our temperature activity range,” added Matheny. “These strains are also showing promise at temperatures below 4°C,” concluded Matheny.

The bacteria covered in the patent are listed as Bacillus sp. This decision was made because the bacteria did not match well to any existing species. Genetic analysis using 16S ribosomal RNA indicated the closest matches were Bacillus simplex or Bacillus butanolivorans. Further testing in the laboratory revealed some major biochemical differences between the newly described Envera strains and the Bacillus simplex and Bacillus butanolivorans type strains.

“I am excited that we may have isolated a new species,” stated co-inventor Dr. Zivile Panaviene. “We are performing additional genetic and biochemical studies to finalize the speciation of these isolates,” added Zivile. “We have 6-12 months of research ahead of us to answer that question, but we are committed to finding the answer,” finished Dr. Panaviene.

“Envera is continually isolating and testing new environmental microbial isolates,” commented Matheny. “We have taken this approach because most of the strains in publically accessible culture collections have been extensively tested, and those strains with positive attributes are available to everyone,” added Matheny. “Envera’s approach is to perform our own microbial isolations to build a proprietary culture collection containing unique organisms with extraordinary attributes,” continued Matheny. “Discovering a group of bacteria with exceptional capabilities, and that may be a new species, is further validation of Envera’s business model,” Matheny added. “We are preparing additional patent filings to cover a number of proprietary microbial strains we isolated over the last few years,” concluded Matheny.

Envera is a bioscience-based company focused on the production of environmentally friendly products. With decades of experience in the isolation, large scale production, stabilization and product formulation of microorganisms, Envera is a leader in the development and commercialization of microbial and enzyme based products for the consumer, institutional, agricultural, waste water, and bioremediation markets. Envera’s technology platform includes expertise in the areas of bacteriology, mycology, enzymology, and chemistry.

Contact: Michael Matheny at mmatheny(at)envera(dot)com or phone 484-593-4002 for more information.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11349076.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Envera Increases Scientific Staff
2. Envera Appoints Michael McErlean Fermentation Manager
3. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
4. Coalition to Save Pure Files Proxy Documents With SEC, Urges Pures Board to Set an Annual Meeting Date
5. Genetics Policy Institute (GPI) Files Additional Legal Arguments in Sherley v. Sebelius Stem Cell Case
6. Human Pheromone Sciences Voluntarily Files With SEC for Termination of Registration
7. 3SBio Inc. Files Annual Report on Form 20-F for Fiscal Year 2011
8. Sequenom, Inc. Files Notice Of Appeal Of Preliminary Injunction Denial
9. Ronald L. Chez Files Amended 13D and Letter to the Board
10. China Cord Blood Corporation Files its Annual Report on Form 20-F
11. Regulus Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... publication of a United States multicenter, prospective clinical study that demonstrates the ... diagnostic test capable of identifying clinically significant acute bacterial and viral respiratory ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the first-ever genomics analysis platform specifically designed for life science researchers to ... of pioneering researcher Rosalind Franklin, who made a major contribution to the ...
(Date:10/11/2017)... ... October 11, 2017 , ... Personal eye wash is a basic first aid supply for ... time. So which eye do you rinse first if a dangerous substance enters both eyes? ... Eye Wash with its unique dual eye piece. , “Whether its dirt and debris, ...
(Date:10/11/2017)...  VMS BioMarketing, a leading provider of patient support solutions, ... Educator (CNE) network, which will launch this week. The VMS ... care professionals to enhance the patient care experience by delivering ... health care professionals to help women who have been diagnosed ... ...
Breaking Biology Technology:
(Date:4/4/2017)... 4, 2017   EyeLock LLC , a leader ... United States Patent and Trademark Office (USPTO) has issued ... linking of an iris image with a face image ... the company,s 45 th issued patent. ... timely given the multi-modal biometric capabilities that have recently ...
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
(Date:3/28/2017)... The report "Video Surveillance Market ... Storage Devices), Software (Video Analytics, VMS), and Service (VSaaS, ... to 2022", published by MarketsandMarkets, the market was valued ... to reach USD 75.64 Billion by 2022, at a ... year considered for the study is 2016 and the ...
Breaking Biology News(10 mins):